돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 473870생성일: 2026년 10월 26일

4-[3-(Trifluoromethyl)phenyl]-4-piperidinol → 1-[(7-bromo-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl)carbonyl]-4-[3-(trifluoromethyl)phenyl]piperidin-4-ol

https://huagongshe.com/reaction/473870

반응식

참여 물질

역할이름HCID투입량
반응물4-[3-(Trifluoromethyl)phenyl]-4-piperidinolHCID 75255—
반응물DiisopropylethylamineHCID 81531—
반응물7-bromo-2,3-dihydro-1,4-benzoxazepine-4(5H)-carbonyl chlorideHCID 86672020—
용매DichloromethaneHCID 6344—
용매Ethyl AcetateHCID 8857—
생성물1-[(7-bromo-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl)carbonyl]-4-[3-(trifluoromethyl)phenyl]piperidin-4-olHCID 69672299100%

반응 단계

A solution of 7-bromo-2,3-dihydro-1,4-benzoxazepine-4(5H)-carbonyl chloride (example 2) (0.400 g, 1.38 mmol), 4-(3-(trifluoromethyl)phenyl)piperidin-4-ol (0.371 g, 1.51 mmol), and diisopropylethylamine (0.535 g, 4.14 mmol) in dichloromethane (3 mL) was stirred at room temperature for 1 hour. The reaction mixture was diluted with ethyl acetate (50 mL), washed with 10% citric acid (20 mL) and brine (20 mL). The organic layer was dried over sodium sulfate. Filtration and concentration afforded 1-[(7-bromo-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl)carbonyl]-4-[3-(trifluoromethyl)phenyl]piperidin-4-ol (0.688 g, 100%) as a white solid that was used without further purification. MS (EI) for C22H22BrF3N2O3: 500 (MH+).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08637499B2
출처 데이터셋uspto-grants-2014_01
ORD IDord-3e1f61430f1a49f780df481a54dbea9d
출처 메모uspto-grants-2014_01